Michał Medygrał
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michał Medygrał has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Julia Buszek
Uniwersytet Rzeszowski
5 shared publications - Weronika Bargiel
Uniwersytet Rzeszowski
5 shared publications - Adrianna Antoszewska
Uniwersytet Rzeszowski
4 shared publications - Piotr Czerniak
Uniwersytet Rzeszowski
4 shared publications - Dominika Bąk
Uniwersytet Rzeszowski
3 shared publications - Halszka Wajdowicz
Uniwersytet Rzeszowski
3 shared publications
Latest Publications
- Open Access
- 22 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 86, 67351
Infertility as a Contemporary Social and Therapeutic Challenge - A Literature Review
INTRODUCTION: Infertility is a multifactorial condition affecting both women and men, with substantial social, psychological, and medical implications. It arises from hormonal, anatomical, genetic, infectious, and lifestyle-related factors. AIM OF STUDY: This review aims to summarize current knowledge on the etiology, pathophysiology, and therapeutic approaches to infertility in both sexes, emphasizing major conditions. MATERIAL AND METHODS: A literature review was conducted analyzing peer-reviewed studies on reproductive health from PubMed and GoogleScholar. Both male and female infertility were considered, focusing on factors influencing gametogenesis, fertilization, embryo implantation and pregnancy outcomes. BASIC RESULTS: In women, infertility is influenced by endometriosis, which alters implantation through inflammatory and immunomodulatory mechanisms; PCOS, which disrupts hormonal balance and ovulation; and uterine fibroids, which impair myometrial contractility and endometrial receptivity. In men, infertility results from genetic and acquired causes, including azoospermia, varicocele, infections, and malignancies, with oxidative stress, antisperm antibodies, and dysbiosis contributing to impaired spermatogenesis and sperm transport. Lifestyle interventions, as well as surgical and pharmacological treatments, can improve reproductive outcomes. CONCLUSION: Infertility is a complex, interrelated condition requiring multidisciplinary management. Understanding biological, genetic, immunological and lifestyle factors is essential to optimize therapy, enhance conception, and increase live birth rates. Targeting modifiable factors such as diet, physical activity, and body weight is a promising adjunct to conventional treatment.
- 22 December 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 86, 67351
Open AccessInfertility as a Contemporary Social and Therapeutic Challenge - A Literature Review
INTRODUCTION: Infertility is a multifactorial condition affecting both women and men, with substantial social, psychological, and medical implications. It arises from hormonal, anatomical, genetic, infectious, and lifestyle-related factors. AIM OF STUDY: This review aims to summarize current knowledge on the etiology, pathophysiology, and therapeutic approaches to infertility in both sexes, emphasizing major conditions. MATERIAL AND METHODS: A literature review was conducted analyzing peer-reviewed studies on reproductive health from PubMed and GoogleScholar. Both male and female infertility were considered, focusing on factors influencing gametogenesis, fertilization, embryo implantation and pregnancy outcomes. BASIC RESULTS: In women, infertility is influenced by endometriosis, which alters implantation through inflammatory and immunomodulatory mechanisms; PCOS, which disrupts hormonal balance and ovulation; and uterine fibroids, which impair myometrial contractility and endometrial receptivity. In men, infertility results from genetic and acquired causes, including azoospermia, varicocele, infections, and malignancies, with oxidative stress, antisperm antibodies, and dysbiosis contributing to impaired spermatogenesis and sperm transport. Lifestyle interventions, as well as surgical and pharmacological treatments, can improve reproductive outcomes. CONCLUSION: Infertility is a complex, interrelated condition requiring multidisciplinary management. Understanding biological, genetic, immunological and lifestyle factors is essential to optimize therapy, enhance conception, and increase live birth rates. Targeting modifiable factors such as diet, physical activity, and body weight is a promising adjunct to conventional treatment.
- Open Access
- 7 July 2025
- Published by Maya Global Education Society in Humanities & Social Sciences Reviews
- Vol. 13 (2) , 122-131
The impact of stress on the pathogenesis and course of selected chronic diseases-A review of the literature
Research objective: To analyze the impact of psychological stress on the pathogenesis, course, and exacerbation of selected autoimmune and neurodegenerative diseases, such as rheumatoid arthritis, psoriasis, systemic lupus erythematosus, Hashimoto’s thyroiditis, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, irritable bowel syndrome, and peptic ulcers. Methodology: A comprehensive literature review was performed using databases including PubMed and Google Scholar. The analysis focused on original articles, meta-analyses, and recent review papers published between 2010 and 2025. Search terms included: stress, autoimmune disease, neurodegeneration, inflammation, HPA axis, psychoneuroimmunology, and specific disease names. Main conclusions: Stress contributes to the onset and progression of various diseases by disrupting the hypothalamic-pituitary-adrenal (HPA) axis, altering cytokine profiles, and impairing immune regulation. Common mechanisms across reviewed diseases include increased levels of pro-inflammatory cytokines, reduced cortisol regulation, and disrupted neuroendocrine signaling. These findings demonstrate a consistent association between chronic psychological stress and increased disease severity. Application of the study: Insights from this review may support the integration of psychological assessments and stress management into treatment plans for patients with autoimmune and neurodegenerative disorders. Incorporating mental health care into standard medical practice could enhance overall treatment effectiveness and improve patient outcomes. Originality/Novelty of the study: This study consolidates current evidence on the role of stress across a broad spectrum of both autoimmune and neurodegenerative diseases, emphasizing shared biological mechanisms and advocating for multidisciplinary approaches in clinical management.
- 7 July 2025
- Published by Maya Global Education Society in Humanities & Social Sciences Reviews
- Vol. 13 (2) , 122-131
Open AccessThe impact of stress on the pathogenesis and course of selected chronic diseases-A review of the literature
Research objective: To analyze the impact of psychological stress on the pathogenesis, course, and exacerbation of selected autoimmune and neurodegenerative diseases, such as rheumatoid arthritis, psoriasis, systemic lupus erythematosus, Hashimoto’s thyroiditis, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, irritable bowel syndrome, and peptic ulcers. Methodology: A comprehensive literature review was performed using databases including PubMed and Google Scholar. The analysis focused on original articles, meta-analyses, and recent review papers published between 2010 and 2025. Search terms included: stress, autoimmune disease, neurodegeneration, inflammation, HPA axis, psychoneuroimmunology, and specific disease names. Main conclusions: Stress contributes to the onset and progression of various diseases by disrupting the hypothalamic-pituitary-adrenal (HPA) axis, altering cytokine profiles, and impairing immune regulation. Common mechanisms across reviewed diseases include increased levels of pro-inflammatory cytokines, reduced cortisol regulation, and disrupted neuroendocrine signaling. These findings demonstrate a consistent association between chronic psychological stress and increased disease severity. Application of the study: Insights from this review may support the integration of psychological assessments and stress management into treatment plans for patients with autoimmune and neurodegenerative disorders. Incorporating mental health care into standard medical practice could enhance overall treatment effectiveness and improve patient outcomes. Originality/Novelty of the study: This study consolidates current evidence on the role of stress across a broad spectrum of both autoimmune and neurodegenerative diseases, emphasizing shared biological mechanisms and advocating for multidisciplinary approaches in clinical management.
- 27 April 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (2)
The role of the ketogenic diet in the treatment of epilepsy in children and adolescents - a review of the literature
Introduction: Epilepsy affects around 50 million people worldwide and is marked by recurrent seizures due to abnormal brain activity. While anticonvulsant medication (ASM) is the standard treatment, about 30% of patients develop drug-resistant epilepsy (DRE), requiring alternative therapies. One such approach is the ketogenic diet (KD), a high-fat, low-carbohydrate regimen that mimics fasting metabolism. Recent research has explored its mechanisms and efficacy in epilepsy management. Aim of the Study: This study evaluates the effectiveness and mechanisms of KD in treating drug-resistant epilepsy in children and adolescents. Materials and Methods: A PubMed analysis was conducted using keywords: ketogenic diet, epilepsy, drug-resistant epilepsy, seizure control, metabolic therapy. Basic Results: Studies confirm KD’s ability to reduce seizure frequency and severity in children with DRE. Over 50% of patients on KD show significant seizure reduction, with some achieving complete freedom. Though side effects like gastrointestinal discomfort and dyslipidemia occur, they are generally manageable. EEG studies suggest KD improves epileptiform discharges, offering broader neurological benefits. Conclusion: KD is a proven, effective therapy for DRE in children, working through increased GABAergic inhibition, metabolic shifts, and neuroprotection. Clinical trials show its ability to reduce seizures, enhance cognition, and improve EEG patterns. While adherence can be difficult, modified versions like MAD offer flexibility. KD’s long-term safety is acceptable, with manageable side effects. Future research should explore its potential as a primary therapy, reducing reliance on ASMs.
- 27 April 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (2)
The role of the ketogenic diet in the treatment of epilepsy in children and adolescents - a review of the literature
Introduction: Epilepsy affects around 50 million people worldwide and is marked by recurrent seizures due to abnormal brain activity. While anticonvulsant medication (ASM) is the standard treatment, about 30% of patients develop drug-resistant epilepsy (DRE), requiring alternative therapies. One such approach is the ketogenic diet (KD), a high-fat, low-carbohydrate regimen that mimics fasting metabolism. Recent research has explored its mechanisms and efficacy in epilepsy management. Aim of the Study: This study evaluates the effectiveness and mechanisms of KD in treating drug-resistant epilepsy in children and adolescents. Materials and Methods: A PubMed analysis was conducted using keywords: ketogenic diet, epilepsy, drug-resistant epilepsy, seizure control, metabolic therapy. Basic Results: Studies confirm KD’s ability to reduce seizure frequency and severity in children with DRE. Over 50% of patients on KD show significant seizure reduction, with some achieving complete freedom. Though side effects like gastrointestinal discomfort and dyslipidemia occur, they are generally manageable. EEG studies suggest KD improves epileptiform discharges, offering broader neurological benefits. Conclusion: KD is a proven, effective therapy for DRE in children, working through increased GABAergic inhibition, metabolic shifts, and neuroprotection. Clinical trials show its ability to reduce seizures, enhance cognition, and improve EEG patterns. While adherence can be difficult, modified versions like MAD offer flexibility. KD’s long-term safety is acceptable, with manageable side effects. Future research should explore its potential as a primary therapy, reducing reliance on ASMs.
- Open Access
- 8 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39
Use of amitriptyline, bupropion and agomelatine in the treatment of non-depressive disorders: a review of mechanisms and therapeutic indications
Introduction Antidepressants such as amitriptyline, bupropion and agomelatine are widely used not only in the treatment of depression, but also in other conditions. Their mechanisms of action affect different neurotransmitter systems, allowing their use in the treatment of pain, addiction or sleep disorders. Amitriptyline, which is a tricyclic antidepressant, has strong analgesic effects. Bupropion, a dopamine and norepinephrine reuptake inhibitor, helps in the treatment of addiction and ADHD. Agomelatine, a melatonin receptor agonist, has been shown to regulate diurnal rhythms, making it useful in the treatment of insomnia and other sleep disorders. Aim of the Study The aim of this study is to analyse the use of amitriptyline, bupropion and agomelatine in the treatment of conditions other than depression, with a focus on their mechanisms of action and clinical efficacy. Materials and Methods An analysis of PubMed papers was conducted using keywords: antidepressants, tricyclic antidepressants, SSRI, amitriptyline, bupropion, agomelatine. Basic Results Amitriptyline is highly effective in the treatment of neuropathic pain, migraines and insomnia due to its potent action on serotonin and histamine receptors. Bupropion is used in the treatment of nicotine addiction and ADHD, as it acts on the dopaminergic and noradrenergic systems to improve concentration and impulse control. Agomelatine, as a melatonin receptor agonist, is used to regulate diurnal rhythms, making it helpful in the treatment of sleep disorders and adaptation to time zone changes. Each of these drugs has unique properties that go beyond their primary use in depression.
- 8 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39
Open AccessUse of amitriptyline, bupropion and agomelatine in the treatment of non-depressive disorders: a review of mechanisms and therapeutic indications
Introduction Antidepressants such as amitriptyline, bupropion and agomelatine are widely used not only in the treatment of depression, but also in other conditions. Their mechanisms of action affect different neurotransmitter systems, allowing their use in the treatment of pain, addiction or sleep disorders. Amitriptyline, which is a tricyclic antidepressant, has strong analgesic effects. Bupropion, a dopamine and norepinephrine reuptake inhibitor, helps in the treatment of addiction and ADHD. Agomelatine, a melatonin receptor agonist, has been shown to regulate diurnal rhythms, making it useful in the treatment of insomnia and other sleep disorders. Aim of the Study The aim of this study is to analyse the use of amitriptyline, bupropion and agomelatine in the treatment of conditions other than depression, with a focus on their mechanisms of action and clinical efficacy. Materials and Methods An analysis of PubMed papers was conducted using keywords: antidepressants, tricyclic antidepressants, SSRI, amitriptyline, bupropion, agomelatine. Basic Results Amitriptyline is highly effective in the treatment of neuropathic pain, migraines and insomnia due to its potent action on serotonin and histamine receptors. Bupropion is used in the treatment of nicotine addiction and ADHD, as it acts on the dopaminergic and noradrenergic systems to improve concentration and impulse control. Agomelatine, as a melatonin receptor agonist, is used to regulate diurnal rhythms, making it helpful in the treatment of sleep disorders and adaptation to time zone changes. Each of these drugs has unique properties that go beyond their primary use in depression.
- Open Access
- 10 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58150
Are Artificial Sweeteners a Healthier Alternative to Sugar?
Introduction Sweeteners are a common sugar alternative, especially in combating obesity and diabetes. With low calorie content, they appeal to health-conscious individuals. The food industry uses natural options like stevia or erythritol and synthetic ones such as aspartame or saccharin. While recognized as safe at recommended doses, debates continue about their long-term effects, emphasizing the need for further research. This paper explores the properties, benefits, and risks of sweeteners. Aim of the Study This study examines the effects of sweeteners on human health and evaluates their suitability as sugar substitutes for modern consumers, highlighting their benefits and potential risks. Materials and Methods An analysis of PubMed papers was conducted using keywords: sweeteners, artificial sweeteners, erythritol, acesulfame potassium, sucralose, aspartame, and sugar alternatives. Basic Results Both natural and synthetic sweeteners are used as sugar substitutes to address concerns about excessive sugar intake. Research indicates they help reduce calorie consumption and control blood sugar levels. However, uncertainties remain about their long-term health effects. Some studies suggest possible changes in metabolism or gut microbiota, but evidence is inconclusive. Regulatory bodies like the FDA deem approved sweeteners safe within recommended daily limits. Despite their advantages, further research is needed to fully understand their long-term impact. Conclusion Sweeteners are gaining popularity as sugar alternatives, particularly in the context of obesity and diabetes. Their variety allows for diverse dietary applications. While safe within recommended doses, questions about their long-term effects persist. They aid in weight control and glucose regulation but are not universally suitable. A balanced approach and further research are crucial.
- 10 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58150
Open AccessAre Artificial Sweeteners a Healthier Alternative to Sugar?
Introduction Sweeteners are a common sugar alternative, especially in combating obesity and diabetes. With low calorie content, they appeal to health-conscious individuals. The food industry uses natural options like stevia or erythritol and synthetic ones such as aspartame or saccharin. While recognized as safe at recommended doses, debates continue about their long-term effects, emphasizing the need for further research. This paper explores the properties, benefits, and risks of sweeteners. Aim of the Study This study examines the effects of sweeteners on human health and evaluates their suitability as sugar substitutes for modern consumers, highlighting their benefits and potential risks. Materials and Methods An analysis of PubMed papers was conducted using keywords: sweeteners, artificial sweeteners, erythritol, acesulfame potassium, sucralose, aspartame, and sugar alternatives. Basic Results Both natural and synthetic sweeteners are used as sugar substitutes to address concerns about excessive sugar intake. Research indicates they help reduce calorie consumption and control blood sugar levels. However, uncertainties remain about their long-term health effects. Some studies suggest possible changes in metabolism or gut microbiota, but evidence is inconclusive. Regulatory bodies like the FDA deem approved sweeteners safe within recommended daily limits. Despite their advantages, further research is needed to fully understand their long-term impact. Conclusion Sweeteners are gaining popularity as sugar alternatives, particularly in the context of obesity and diabetes. Their variety allows for diverse dietary applications. While safe within recommended doses, questions about their long-term effects persist. They aid in weight control and glucose regulation but are not universally suitable. A balanced approach and further research are crucial.
- Open Access
- 2 June 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (11) , 1629
Indexing of Speckle Tracking Longitudinal Strain of Right Ventricle to Body Surface Area Does Not Improve Its Efficiency in Diagnosis and Mortality Risk Stratification in Patients with Acute Pulmonary Embolism
Background: Acute pulmonary embolism (PE) is associated with a serious mortality rate. Thus, the rapid diagnosis and identification of patients at high risk of death is pivotal. The search for echocardiographic parameters for this purpose continues. Recent publications reveal correlations between myocardial longitudinal strain (LS) and body surface area (BSA). The aim of the study was to evaluate the usefulness of indexing the right ventricular (RV) speckle tracking LS to BSA in detecting PE and stratifying the risk of 30-day all-cause mortality. Methods: the prospective cross-sectional observational study group consisted of 167 consecutive patients (76 men, 45.5%) aged 69.5 ± 15.3 years, and they were referred for computed tomography pulmonary angiography. Patients underwent a transthoracic echocardiographic examination within 24 h of admission to the hospital ward. RVLS and their derivatives indexed to BSA were included in the analysis. Results: PE was confirmed in 88 patients, while 79 patients had no radiological features of PE. The only echocardiographic parameters that differed between subgroups were pulmonary flow acceleration (Act), McConnell’s sign, LS of the middle segment of the RV free wall, and its derivative indexed to BSA. During the 30-day follow-up of a subgroup of subjects with PE, 12 patients died. The mortality predictors with increasing prediction value included a RV free wall mid-segment LS (cut-off value: −21%, Area Under the Curve—AUC 0.6, p = 0.02) and its derivative indexed to BSA (−14 %/m2, AUC 0.62, p = 0.003), body mass index (24.7 kg/m2, AUC 0.63, p = 0.002), D-dimer serum concentration (3559 pg/mL, AUC 0.66, p < 0.001), Act (67 ms, AUC 0.67, p < 0.001), septal basal LS (−15%, AUC 0.68, p = 0.02), RV free wall basal segment LS (−14%, AUC 0.7, p = 0.015), age (66 years, AUC 0.74, p = 0.004), NT-proBNP (1120 pg/mL, AUC 0.75, p = 0.01), troponin T (66 ng/mL, AUC 0.78, p = 0.005), and the complex score of the Pulmonary Embolism Severity Index (AUC 0.88, p < 0.001). Conclusions: indexing of RVLS to BSA does not improve its prognostic value in patients with acute PE.
- 2 June 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (11) , 1629
Open AccessIndexing of Speckle Tracking Longitudinal Strain of Right Ventricle to Body Surface Area Does Not Improve Its Efficiency in Diagnosis and Mortality Risk Stratification in Patients with Acute Pulmonary Embolism
Background: Acute pulmonary embolism (PE) is associated with a serious mortality rate. Thus, the rapid diagnosis and identification of patients at high risk of death is pivotal. The search for echocardiographic parameters for this purpose continues. Recent publications reveal correlations between myocardial longitudinal strain (LS) and body surface area (BSA). The aim of the study was to evaluate the usefulness of indexing the right ventricular (RV) speckle tracking LS to BSA in detecting PE and stratifying the risk of 30-day all-cause mortality. Methods: the prospective cross-sectional observational study group consisted of 167 consecutive patients (76 men, 45.5%) aged 69.5 ± 15.3 years, and they were referred for computed tomography pulmonary angiography. Patients underwent a transthoracic echocardiographic examination within 24 h of admission to the hospital ward. RVLS and their derivatives indexed to BSA were included in the analysis. Results: PE was confirmed in 88 patients, while 79 patients had no radiological features of PE. The only echocardiographic parameters that differed between subgroups were pulmonary flow acceleration (Act), McConnell’s sign, LS of the middle segment of the RV free wall, and its derivative indexed to BSA. During the 30-day follow-up of a subgroup of subjects with PE, 12 patients died. The mortality predictors with increasing prediction value included a RV free wall mid-segment LS (cut-off value: −21%, Area Under the Curve—AUC 0.6, p = 0.02) and its derivative indexed to BSA (−14 %/m2, AUC 0.62, p = 0.003), body mass index (24.7 kg/m2, AUC 0.63, p = 0.002), D-dimer serum concentration (3559 pg/mL, AUC 0.66, p < 0.001), Act (67 ms, AUC 0.67, p < 0.001), septal basal LS (−15%, AUC 0.68, p = 0.02), RV free wall basal segment LS (−14%, AUC 0.7, p = 0.015), age (66 years, AUC 0.74, p = 0.004), NT-proBNP (1120 pg/mL, AUC 0.75, p = 0.01), troponin T (66 ng/mL, AUC 0.78, p = 0.005), and the complex score of the Pulmonary Embolism Severity Index (AUC 0.88, p < 0.001). Conclusions: indexing of RVLS to BSA does not improve its prognostic value in patients with acute PE.